1
|
Gately M, Waller D, Metcalf E, Moo L. FINDINGS FROM HIGH USERS OF VIDEO TELEHEALTH TO DELIVER OCCUPATIONAL THERAPY SERVICES DURING COVID-19. Innov Aging 2022. [PMCID: PMC9767106 DOI: 10.1093/geroni/igac059.2234] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Abstract
Occupational therapy (OT) helps older adults improve their ability to perform day-to-day tasks. Veterans Health Administration (VHA) is the single largest employer of occupational therapy (OT) practitioners in the United States and a forerunner in telehealth. As a result of COVID, OT video visits increased by nearly 2000% from 2019 to 2020. To ascertain barriers and facilitators to this shift in care delivery, we conducted interviews between January and April 2021 with OT practitioners (N=27) who were high users of VA Video Connect (VVC), VHA’s videoconferencing software. OT participants were from rural and urban settings, and had completed an average of 536 VVC appointments each in 2020. Participants used VVC to deliver a variety of OT services, including mental health groups and home safety interventions. Facilitators to VVC included, a) Patient characteristics, such as positive perceptions of VVC and technological skill, b) OT clinician characteristics, like flexibility, level of experience, and desire to increase patient access to care, and, c) VHA’s telehealth infrastructure. Barriers included, a) Patients’ lack of familiarity or skills with technology, particularly older patients, b) challenges translating traditionally hands-on care to video, and c) unreliable internet connectivity, particularly for rural patients. This study broadens our understanding of video telehealth service delivery for care which has historically been delivered in brick-and-mortar settings. Understanding challenges and enablers to video telehealth highlights opportunities to increase access to those who face barriers, such as older, rural patients.
Collapse
Affiliation(s)
- Megan Gately
- VA Bedford Health Care System, Bedford, Massachusetts, United States
| | - Dylan Waller
- VA Portland Health Care System, Portland, Oregon, United States
| | - Emily Metcalf
- VA Bedford Health Care System, Bedford, Massachusetts, United States
| | - Lauren Moo
- VA Bedford Health Care System, Bedford, Massachusetts, United States
| |
Collapse
|
2
|
Gately M, Waller D, Metcalf E, Moo L. CAREGIVER CONTRIBUTION TO OCCUPATIONAL THERAPY VIDEO VISITS. Innov Aging 2022. [PMCID: PMC9766605 DOI: 10.1093/geroni/igac059.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Abstract
Caregivers’ role facilitating older adults’ participation in diverse health care services delivered using video telehealth (i.e., live sessions) is not well-understood. This study surveyed occupational therapy (OT) practitioners across Veterans Health Administration (VHA) about caregiver participation in VA Video Connect (VVC), VHA’s videoconferencing platform. 293 OT practitioners participated in the survey, with 47% reporting that caregivers participated in VVC often. The foremost reported patient factors necessitating caregiver participation in video visits were patient lack of technical skills (76%) and cognitive impairment (72%). Barriers to caregiver participation in video visits included poor connectivity and caregivers’ own age or health related impairments, while benefits included increased collaboration with family (87%). This study enhances our understanding of caregivers’ participation in video telehealth, highlighting factors driving caregiver participation and suggesting strategies to optimize this service delivery format for older adults.
Collapse
Affiliation(s)
- Megan Gately
- VA Bedford Health Care System, Bedford, Massachusetts, United States
| | - Dylan Waller
- VA Portland Health Care System, Portland, Oregon, United States
| | - Emily Metcalf
- VA Bedford Health Care System, Bedford, Massachusetts, United States
| | - Lauren Moo
- VA Bedford Health Care System, Bedford, Massachusetts, United States
| |
Collapse
|
3
|
Rasmussen R, Levari DE, Akhtar M, Crittle CS, Gately M, Pagan J, Brennen A, Cashman D, Wulff AN, Norton MI, Sommers SR, Urry HL. White (but Not Black) Americans Continue to See Racism as a Zero-Sum Game; White Conservatives (but Not Moderates or Liberals) See Themselves as Losing. Perspect Psychol Sci 2022; 17:1800-1810. [PMID: 35867341 DOI: 10.1177/17456916221082111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
In a 2011 article in this journal entitled "Whites See Racism as a Zero-Sum Game That They Are Now Losing" (Perspectives on Psychological Science, 6, 215-218), Norton and Sommers assessed Black and White Americans' perceptions of anti-Black and anti-White bias across the previous 6 decades-from the 1950s to the 2000s. They presented two key findings: White (but not Black) respondents perceived decreases in anti-Black bias to be associated with increases in anti-White bias, signaling the perception that racism is a zero-sum game; White respondents rated anti-White bias as more pronounced than anti-Black bias in the 2000s, signaling the perception that they were losing the zero-sum game. We collected new data to examine whether the key findings would be evident nearly a decade later and whether political ideology would moderate perceptions. Liberal, moderate, and conservative White (but not Black) Americans alike believed that racism is a zero-sum game. Liberal White Americans saw racism as a zero-sum game they were winning by a lot, moderate White Americans saw it as a game they were winning by only a little, and conservative White Americans saw it as a game they were losing. This work has clear implications for public policy and behavioral science and lays the groundwork for future research that examines to what extent racial differences in perceptions of racism by political ideology are changing over time.
Collapse
Affiliation(s)
| | - David E Levari
- Negotiation, Organizations & Markets, Harvard Business School
| | | | | | - Megan Gately
- New England Geriatric Research Education and Clinical Center, VA Bedford Health Care System, Bedford, Massachusetts
| | | | | | | | | | | | | | | |
Collapse
|
4
|
Barczi S, Gately M, Welch L, Nearing K, Thielke S, Pimentel C, Previll L, Dryden E. Spreading Telehealth for Older Adults in Rural Areas Through Network of Geriatric Interprofessional Teams. Innov Aging 2020. [PMCID: PMC7743215 DOI: 10.1093/geroni/igaa057.2885] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
Abstract
Older adults living in rural areas have limited access to geriatrics interprofessional team care. In the Veteran healthcare system, geriatric teams such as geriatricians, nursing professionals, social workers, pharmacists and psychologists, located in urban areas link up with rural clinics to provide geriatric consultation remotely through clinical video telehealth and other means in the project GRECC Connect. Since its inception in 2014, the service has now grown to 16 geriatric teams offering consultation to over 100 clinic sites serving older rural Veterans. GRECC Connect delivered over 2,000 consultations in 2019, meeting complex care needs by identifying and linking geriatric services and management to patients with geriatric syndromes. The network of established geriatric teams, local champions and a shared Electronic Health Record facilitated the spread, while ongoing effort to build and maintain relationships between consultants and local rural provider teams and other community based services are important for ongoing success.
Collapse
Affiliation(s)
- Steven Barczi
- University of Wisconsin, Madison; William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin, United States
| | - Megan Gately
- Bedford VA Medical Center, Bedford, Massachusetts, United States
| | - Lauren Welch
- William S Middleton VAMC GRECC, Madison, Wisconsin, United States
| | - Kathryn Nearing
- University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
| | - Stephen Thielke
- VA Puget Sound Health Care System, Seattle, Washington, United States
| | - Camilla Pimentel
- Edith Nourse Rogers Memorial Veterans Hospital, Center for Heallthcare Organization and Implementation research, Bedford, Massachusetts, United States
| | - Laura Previll
- Duke University School of Medicine, Durham, North Carolina, United States
| | - Eileen Dryden
- Center for Health Care Implementation Research (CHOIR), Bedford, Maryland, United States
| |
Collapse
|
5
|
Gately M, Moo L. In-Home Video Telehealth for Caregivers and Veterans With Dementia. Innov Aging 2020. [PMCID: PMC7742470 DOI: 10.1093/geroni/igaa057.2285] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Abstract
Home Video Telehealth offers a unique opportunity to support already burdened caregivers of persons with dementia. Veterans Health Administration, through the MISSION Act, is increasingly using video telehealth to provide “care at the right time and in the right place.” Little is known about the benefits and challenges of using video telehealth for in-home caregiver support. We present findings from our seven years offering in-home dementia management to caregivers of Veterans with dementia, that includes supporting caregivers through supportive listening, tips for communication and safety strategies, and recommendations regarding non-pharmacologic management of behaviors. Perceived benefits of in-home video telehealth include an ‘in vivo’ perspective of the family’s natural context and remediating barriers to care such as decreased mobility. Perceived challenges include dealing with technology and privacy concerns. By describing considerations for in-home video telehealth to a clinical population with unique care needs, we inform broader application of a promising technology.
Collapse
Affiliation(s)
- Megan Gately
- Bedford VA Medical Center, Bedford, Massachusetts, United States
| | - Lauren Moo
- Bedford VA Medical Center, Bedford, Massachusetts, United States
| |
Collapse
|
6
|
Nearing KA, Lum HD, Dang S, Powers B, McLaren J, Gately M, Hung W, Moo L. National Geriatric Network Rapidly Addresses Trainee Telehealth Needs in Response to COVID-19. J Am Geriatr Soc 2020; 68:1907-1912. [PMID: 32639578 PMCID: PMC7361851 DOI: 10.1111/jgs.16704] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2020] [Revised: 06/08/2020] [Accepted: 06/12/2020] [Indexed: 12/16/2022]
Abstract
BACKGROUND/OBJECTIVES Coronavirus disease 2019 (COVID‐19) has pushed many geriatric healthcare providers to attempt video visits for the first time. Although the Veterans Health Administration (VA) is a pioneer in telemedicine, rapid shifts to nearly exclusive use of telehealth for healthcare delivery and changes regarding trainee engagement in telehealth served as the impetus for rapidly assessing telehealth training needs. DESIGN National needs assessment (online survey) of associated health trainees and medical fellows affiliated with Geriatric Research Education and Clinical Centers (GRECCs). SETTING National GRECC network ‐‐ 20 VA centers of excellence focused on supporting Veterans as they age. Each GRECC is affiliated with a school of medicine at a major university. PARTICIPANTS Trainees (n = 89) representing 12 disciplines. RESULTS Two‐thirds of participants had received some telehealth training. However, most had never done a video‐to‐home visit, and, regardless of telehealth experience, they reported low confidence. Based on open‐ended questions exploring training needs, educational resources were rapidly developed and disseminated. INTERVENTION Within 1 week of the assessment, a nuts‐and‐bolts guide regarding remote access, technology requirements, video‐conferencing platforms, and managing emergencies was sent to the national network of GRECC associate directors for education for dissemination among discipline‐specific training directors at their sites. This resource was subsequently submitted to the national VA COVID Strong Practices SharePoint site. An interdisciplinary team of geriatric specialists with extensive video‐to‐home experience also organized a national webinar that peaked at just over 700 participants. GRECC Connect, a network of geriatric specialty teams funded to improve care access for rural older veterans using telehealth and associated health training programs at each GRECC facilitated rapid development and dissemination of both resources. CONCLUSION We quickly identified and responded to telehealth training needs of geriatrics trainees to optimize care for rural older adults as part of a rapid response to COVID‐19. Although the webinar and nuts‐and‐bolts resources were developed within the VA context, they have demonstrated high demand and broader applicability. Results should continue to inform curriculum development efforts to address telehealth training gaps within and outside the VA.
Collapse
Affiliation(s)
- Kathryn A Nearing
- Eastern Colorado VA Geriatric Research Education and Clinical Center, Aurora, Colorado, USA.,Division of Geriatric Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA
| | - Hillary D Lum
- Eastern Colorado VA Geriatric Research Education and Clinical Center, Aurora, Colorado, USA.,Division of Geriatric Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA
| | - Stuti Dang
- Miami Veterans Affairs Healthcare System, Miami, Florida, USA.,Division of Geriatrics and Palliative Medicine, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA.,Miami Veterans Affairs Healthcare System Geriatric Research Education and Clinical Center, Miami, Florida, USA
| | - Becky Powers
- University of Texas Health Science Center, San Antonio, Texas, USA.,South Texas Veterans Healthcare System Geriatrics Research Education and Clinical Center, San Antonio, Texas, USA
| | - Jaye McLaren
- Bedford VA Medical Center, Division of the New England Geriatric Research Education and Clinical Center, Bedford, Massachusetts, USA
| | - Megan Gately
- Bedford VA Medical Center, Division of the New England Geriatric Research Education and Clinical Center, Bedford, Massachusetts, USA
| | - William Hung
- Bronx Geriatric Research Education and Clinical Center, James J. Peters VA Medical Center, Bronx, New York, USA.,Icahn School of Medicine, Mount Sinai, New York, USA
| | - Lauren Moo
- Bedford VA Medical Center, Division of the New England Geriatric Research Education and Clinical Center, Bedford, Massachusetts, USA.,Harvard Medicine School, Boston, Massachusetts, USA
| |
Collapse
|
7
|
Gately M, Tickle-Degnen L, Ladin K, Ward N, Moo L. Use of Video Telehealth to Serve Geriatric Veterans: A National Survey of Veterans Health Administration OT Practitioners. Am J Occup Ther 2020. [DOI: 10.5014/ajot.2020.74s1-po6315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Abstract
Date Presented 03/27/20
Little is known about utilization of video telehealth with older clients by OT practitioners. Of 322 OT practitioners at the Veterans Health Administration participating in a web-based survey, 41% use video telehealth with older clients. The primary facilitator reflected practitioner attitudes, while the primary barrier was institutional. Findings highlight key person-level and system-level factors in implementation of video telehealth for older clients.
Primary Author and Speaker: Megan Gately
Additional Authors and Speakers: Tickle-Degnen Linda, Keren Ladin, Lauren Moo
Contributing Authors: Ward Nathan
Collapse
Affiliation(s)
- Megan Gately
- Tufts University, Medford, MA, USA, Geriatric Research Education and Clinical Center, Bedford, MA, USA
| | | | | | | | - Lauren Moo
- Massachusetts General Hospital, Boston, MA, USA, Geriatric Research Education and Clinical Center, Bedford, MA, USA
| |
Collapse
|
8
|
Gately M. CAREGIVER EXPERIENCE OF TELEHEALTH-DELIVERED HOME SAFETY EVALUATIONS. Innov Aging 2019. [PMCID: PMC6844698 DOI: 10.1093/geroni/igz038.912] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
People with dementia are living in the community, necessitating in-home supports for their day-to-day needs. Given geriatrics work force shortages, innovative strategies that increase the reach of extant providers while maintaining quality are needed. Home-based video telehealth may increase access to specialty care such as a dementia-focused home safety evaluation by an occupational therapist; however, little is known about the technological demands and caregiver experience of a home safety evaluation delivered by telehealth. Our study employed video telehealth to deliver a dementia-focused home safety evaluation compared to in-person evaluation for caregivers (n=10) of veterans with dementia. Most video visits encountered technological problems. Caregiver experience between the video and in-person evaluations differed. Our findings reflect the highly dynamic, complex nature of in-home video telehealth which requires maximal collaboration with caregivers. By explicating the resource demands and potential burden of video telehealth for caregivers, development of effective in-home telehealth evaluation is enhanced
Collapse
Affiliation(s)
- Megan Gately
- Bedford VA Medical Center Geriatric Research, Education & Clinical Center, Bedford, Massachusetts, United States
| |
Collapse
|
9
|
Pimentel CB, Gately M, Barczi SR, Boockvar KS, Bowman EH, Caprio TV, Colón-Emeric CS, Dang S, Espinoza SE, Garner KK, Griffiths PC, Howe JL, Lum HD, Markland AD, Rossi MI, Thielke SM, Valencia-Rodrigo WM, Moo LR, Hung WW. GRECC Connect: Geriatrics Telehealth to Empower Health Care Providers and Improve Management of Older Veterans in Rural Communities. Fed Pract 2019; 36:464-470. [PMID: 31768097 PMCID: PMC6837335] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
A telehealth program supports meaningful partnerships between urban geriatric specialists and rural health care providers to facilitate increased access to specialty care.
Collapse
Affiliation(s)
- Camilla B Pimentel
- is a Research Health Scientist at the Center for Healthcare Organization and Implementation Research and the New England Geriatric Research Education and Clinical Center (GRECC), and is a Program Manager and is Site Director at the New England GRECC, Edith Nourse Rogers Memorial Veterans Hospital in Bedford, Massachusetts. is a Physician at Madison GRECC, William S. Middleton Memorial Veterans Hospital in Wisconsin. is Associate Director (research), J is Deputy Director, and is Associate Director (clinical) at Bronx/NY Harbor GRECC, James J. Peters Veterans Affairs Medical Center in New York. is a Geriatrician and is Associate Director (clinical) at the Birmingham/Atlanta GRECC in Alabama. is a Geriatrician at the Canandaigua VA Medical Center in New York. is Associate Director (clinical) at the Durham GRECC, Durham VA Medical Center in North Carolina. and are Geriatricians at the Miami GRECC, Miami VA Healthcare System in Florida. is Associate Director (clinical) at the San Antonio GRECC, Audie L. Murphy Memorial VA Hospital in Texas. is Associate Director (education & evaluation) at the Little Rock GRECC, Central Arkansas Veterans Healthcare System. is a Research Health Scientist at the Birmingham/Atlanta GRECC, Atlanta VA Medical Center in Decatur, Georgia. is a Geriatrician at the Eastern Colorado GRECC, VA Eastern Colorado Health Care System in Denver. is Associate Director (clinical) at the Pittsburgh GRECC, VA Pittsburgh Healthcare System in Pennsylvania. is Associate Director (education & evaluation) at the Puget Sound GRECC, Puget Sound VA Medical Center in Seattle, Washington
| | - Megan Gately
- is a Research Health Scientist at the Center for Healthcare Organization and Implementation Research and the New England Geriatric Research Education and Clinical Center (GRECC), and is a Program Manager and is Site Director at the New England GRECC, Edith Nourse Rogers Memorial Veterans Hospital in Bedford, Massachusetts. is a Physician at Madison GRECC, William S. Middleton Memorial Veterans Hospital in Wisconsin. is Associate Director (research), J is Deputy Director, and is Associate Director (clinical) at Bronx/NY Harbor GRECC, James J. Peters Veterans Affairs Medical Center in New York. is a Geriatrician and is Associate Director (clinical) at the Birmingham/Atlanta GRECC in Alabama. is a Geriatrician at the Canandaigua VA Medical Center in New York. is Associate Director (clinical) at the Durham GRECC, Durham VA Medical Center in North Carolina. and are Geriatricians at the Miami GRECC, Miami VA Healthcare System in Florida. is Associate Director (clinical) at the San Antonio GRECC, Audie L. Murphy Memorial VA Hospital in Texas. is Associate Director (education & evaluation) at the Little Rock GRECC, Central Arkansas Veterans Healthcare System. is a Research Health Scientist at the Birmingham/Atlanta GRECC, Atlanta VA Medical Center in Decatur, Georgia. is a Geriatrician at the Eastern Colorado GRECC, VA Eastern Colorado Health Care System in Denver. is Associate Director (clinical) at the Pittsburgh GRECC, VA Pittsburgh Healthcare System in Pennsylvania. is Associate Director (education & evaluation) at the Puget Sound GRECC, Puget Sound VA Medical Center in Seattle, Washington
| | - Steven R Barczi
- is a Research Health Scientist at the Center for Healthcare Organization and Implementation Research and the New England Geriatric Research Education and Clinical Center (GRECC), and is a Program Manager and is Site Director at the New England GRECC, Edith Nourse Rogers Memorial Veterans Hospital in Bedford, Massachusetts. is a Physician at Madison GRECC, William S. Middleton Memorial Veterans Hospital in Wisconsin. is Associate Director (research), J is Deputy Director, and is Associate Director (clinical) at Bronx/NY Harbor GRECC, James J. Peters Veterans Affairs Medical Center in New York. is a Geriatrician and is Associate Director (clinical) at the Birmingham/Atlanta GRECC in Alabama. is a Geriatrician at the Canandaigua VA Medical Center in New York. is Associate Director (clinical) at the Durham GRECC, Durham VA Medical Center in North Carolina. and are Geriatricians at the Miami GRECC, Miami VA Healthcare System in Florida. is Associate Director (clinical) at the San Antonio GRECC, Audie L. Murphy Memorial VA Hospital in Texas. is Associate Director (education & evaluation) at the Little Rock GRECC, Central Arkansas Veterans Healthcare System. is a Research Health Scientist at the Birmingham/Atlanta GRECC, Atlanta VA Medical Center in Decatur, Georgia. is a Geriatrician at the Eastern Colorado GRECC, VA Eastern Colorado Health Care System in Denver. is Associate Director (clinical) at the Pittsburgh GRECC, VA Pittsburgh Healthcare System in Pennsylvania. is Associate Director (education & evaluation) at the Puget Sound GRECC, Puget Sound VA Medical Center in Seattle, Washington
| | - Kenneth S Boockvar
- is a Research Health Scientist at the Center for Healthcare Organization and Implementation Research and the New England Geriatric Research Education and Clinical Center (GRECC), and is a Program Manager and is Site Director at the New England GRECC, Edith Nourse Rogers Memorial Veterans Hospital in Bedford, Massachusetts. is a Physician at Madison GRECC, William S. Middleton Memorial Veterans Hospital in Wisconsin. is Associate Director (research), J is Deputy Director, and is Associate Director (clinical) at Bronx/NY Harbor GRECC, James J. Peters Veterans Affairs Medical Center in New York. is a Geriatrician and is Associate Director (clinical) at the Birmingham/Atlanta GRECC in Alabama. is a Geriatrician at the Canandaigua VA Medical Center in New York. is Associate Director (clinical) at the Durham GRECC, Durham VA Medical Center in North Carolina. and are Geriatricians at the Miami GRECC, Miami VA Healthcare System in Florida. is Associate Director (clinical) at the San Antonio GRECC, Audie L. Murphy Memorial VA Hospital in Texas. is Associate Director (education & evaluation) at the Little Rock GRECC, Central Arkansas Veterans Healthcare System. is a Research Health Scientist at the Birmingham/Atlanta GRECC, Atlanta VA Medical Center in Decatur, Georgia. is a Geriatrician at the Eastern Colorado GRECC, VA Eastern Colorado Health Care System in Denver. is Associate Director (clinical) at the Pittsburgh GRECC, VA Pittsburgh Healthcare System in Pennsylvania. is Associate Director (education & evaluation) at the Puget Sound GRECC, Puget Sound VA Medical Center in Seattle, Washington
| | - Ella H Bowman
- is a Research Health Scientist at the Center for Healthcare Organization and Implementation Research and the New England Geriatric Research Education and Clinical Center (GRECC), and is a Program Manager and is Site Director at the New England GRECC, Edith Nourse Rogers Memorial Veterans Hospital in Bedford, Massachusetts. is a Physician at Madison GRECC, William S. Middleton Memorial Veterans Hospital in Wisconsin. is Associate Director (research), J is Deputy Director, and is Associate Director (clinical) at Bronx/NY Harbor GRECC, James J. Peters Veterans Affairs Medical Center in New York. is a Geriatrician and is Associate Director (clinical) at the Birmingham/Atlanta GRECC in Alabama. is a Geriatrician at the Canandaigua VA Medical Center in New York. is Associate Director (clinical) at the Durham GRECC, Durham VA Medical Center in North Carolina. and are Geriatricians at the Miami GRECC, Miami VA Healthcare System in Florida. is Associate Director (clinical) at the San Antonio GRECC, Audie L. Murphy Memorial VA Hospital in Texas. is Associate Director (education & evaluation) at the Little Rock GRECC, Central Arkansas Veterans Healthcare System. is a Research Health Scientist at the Birmingham/Atlanta GRECC, Atlanta VA Medical Center in Decatur, Georgia. is a Geriatrician at the Eastern Colorado GRECC, VA Eastern Colorado Health Care System in Denver. is Associate Director (clinical) at the Pittsburgh GRECC, VA Pittsburgh Healthcare System in Pennsylvania. is Associate Director (education & evaluation) at the Puget Sound GRECC, Puget Sound VA Medical Center in Seattle, Washington
| | - Thomas V Caprio
- is a Research Health Scientist at the Center for Healthcare Organization and Implementation Research and the New England Geriatric Research Education and Clinical Center (GRECC), and is a Program Manager and is Site Director at the New England GRECC, Edith Nourse Rogers Memorial Veterans Hospital in Bedford, Massachusetts. is a Physician at Madison GRECC, William S. Middleton Memorial Veterans Hospital in Wisconsin. is Associate Director (research), J is Deputy Director, and is Associate Director (clinical) at Bronx/NY Harbor GRECC, James J. Peters Veterans Affairs Medical Center in New York. is a Geriatrician and is Associate Director (clinical) at the Birmingham/Atlanta GRECC in Alabama. is a Geriatrician at the Canandaigua VA Medical Center in New York. is Associate Director (clinical) at the Durham GRECC, Durham VA Medical Center in North Carolina. and are Geriatricians at the Miami GRECC, Miami VA Healthcare System in Florida. is Associate Director (clinical) at the San Antonio GRECC, Audie L. Murphy Memorial VA Hospital in Texas. is Associate Director (education & evaluation) at the Little Rock GRECC, Central Arkansas Veterans Healthcare System. is a Research Health Scientist at the Birmingham/Atlanta GRECC, Atlanta VA Medical Center in Decatur, Georgia. is a Geriatrician at the Eastern Colorado GRECC, VA Eastern Colorado Health Care System in Denver. is Associate Director (clinical) at the Pittsburgh GRECC, VA Pittsburgh Healthcare System in Pennsylvania. is Associate Director (education & evaluation) at the Puget Sound GRECC, Puget Sound VA Medical Center in Seattle, Washington
| | - Cathleen S Colón-Emeric
- is a Research Health Scientist at the Center for Healthcare Organization and Implementation Research and the New England Geriatric Research Education and Clinical Center (GRECC), and is a Program Manager and is Site Director at the New England GRECC, Edith Nourse Rogers Memorial Veterans Hospital in Bedford, Massachusetts. is a Physician at Madison GRECC, William S. Middleton Memorial Veterans Hospital in Wisconsin. is Associate Director (research), J is Deputy Director, and is Associate Director (clinical) at Bronx/NY Harbor GRECC, James J. Peters Veterans Affairs Medical Center in New York. is a Geriatrician and is Associate Director (clinical) at the Birmingham/Atlanta GRECC in Alabama. is a Geriatrician at the Canandaigua VA Medical Center in New York. is Associate Director (clinical) at the Durham GRECC, Durham VA Medical Center in North Carolina. and are Geriatricians at the Miami GRECC, Miami VA Healthcare System in Florida. is Associate Director (clinical) at the San Antonio GRECC, Audie L. Murphy Memorial VA Hospital in Texas. is Associate Director (education & evaluation) at the Little Rock GRECC, Central Arkansas Veterans Healthcare System. is a Research Health Scientist at the Birmingham/Atlanta GRECC, Atlanta VA Medical Center in Decatur, Georgia. is a Geriatrician at the Eastern Colorado GRECC, VA Eastern Colorado Health Care System in Denver. is Associate Director (clinical) at the Pittsburgh GRECC, VA Pittsburgh Healthcare System in Pennsylvania. is Associate Director (education & evaluation) at the Puget Sound GRECC, Puget Sound VA Medical Center in Seattle, Washington
| | - Stuti Dang
- is a Research Health Scientist at the Center for Healthcare Organization and Implementation Research and the New England Geriatric Research Education and Clinical Center (GRECC), and is a Program Manager and is Site Director at the New England GRECC, Edith Nourse Rogers Memorial Veterans Hospital in Bedford, Massachusetts. is a Physician at Madison GRECC, William S. Middleton Memorial Veterans Hospital in Wisconsin. is Associate Director (research), J is Deputy Director, and is Associate Director (clinical) at Bronx/NY Harbor GRECC, James J. Peters Veterans Affairs Medical Center in New York. is a Geriatrician and is Associate Director (clinical) at the Birmingham/Atlanta GRECC in Alabama. is a Geriatrician at the Canandaigua VA Medical Center in New York. is Associate Director (clinical) at the Durham GRECC, Durham VA Medical Center in North Carolina. and are Geriatricians at the Miami GRECC, Miami VA Healthcare System in Florida. is Associate Director (clinical) at the San Antonio GRECC, Audie L. Murphy Memorial VA Hospital in Texas. is Associate Director (education & evaluation) at the Little Rock GRECC, Central Arkansas Veterans Healthcare System. is a Research Health Scientist at the Birmingham/Atlanta GRECC, Atlanta VA Medical Center in Decatur, Georgia. is a Geriatrician at the Eastern Colorado GRECC, VA Eastern Colorado Health Care System in Denver. is Associate Director (clinical) at the Pittsburgh GRECC, VA Pittsburgh Healthcare System in Pennsylvania. is Associate Director (education & evaluation) at the Puget Sound GRECC, Puget Sound VA Medical Center in Seattle, Washington
| | - Sara E Espinoza
- is a Research Health Scientist at the Center for Healthcare Organization and Implementation Research and the New England Geriatric Research Education and Clinical Center (GRECC), and is a Program Manager and is Site Director at the New England GRECC, Edith Nourse Rogers Memorial Veterans Hospital in Bedford, Massachusetts. is a Physician at Madison GRECC, William S. Middleton Memorial Veterans Hospital in Wisconsin. is Associate Director (research), J is Deputy Director, and is Associate Director (clinical) at Bronx/NY Harbor GRECC, James J. Peters Veterans Affairs Medical Center in New York. is a Geriatrician and is Associate Director (clinical) at the Birmingham/Atlanta GRECC in Alabama. is a Geriatrician at the Canandaigua VA Medical Center in New York. is Associate Director (clinical) at the Durham GRECC, Durham VA Medical Center in North Carolina. and are Geriatricians at the Miami GRECC, Miami VA Healthcare System in Florida. is Associate Director (clinical) at the San Antonio GRECC, Audie L. Murphy Memorial VA Hospital in Texas. is Associate Director (education & evaluation) at the Little Rock GRECC, Central Arkansas Veterans Healthcare System. is a Research Health Scientist at the Birmingham/Atlanta GRECC, Atlanta VA Medical Center in Decatur, Georgia. is a Geriatrician at the Eastern Colorado GRECC, VA Eastern Colorado Health Care System in Denver. is Associate Director (clinical) at the Pittsburgh GRECC, VA Pittsburgh Healthcare System in Pennsylvania. is Associate Director (education & evaluation) at the Puget Sound GRECC, Puget Sound VA Medical Center in Seattle, Washington
| | - Kimberly K Garner
- is a Research Health Scientist at the Center for Healthcare Organization and Implementation Research and the New England Geriatric Research Education and Clinical Center (GRECC), and is a Program Manager and is Site Director at the New England GRECC, Edith Nourse Rogers Memorial Veterans Hospital in Bedford, Massachusetts. is a Physician at Madison GRECC, William S. Middleton Memorial Veterans Hospital in Wisconsin. is Associate Director (research), J is Deputy Director, and is Associate Director (clinical) at Bronx/NY Harbor GRECC, James J. Peters Veterans Affairs Medical Center in New York. is a Geriatrician and is Associate Director (clinical) at the Birmingham/Atlanta GRECC in Alabama. is a Geriatrician at the Canandaigua VA Medical Center in New York. is Associate Director (clinical) at the Durham GRECC, Durham VA Medical Center in North Carolina. and are Geriatricians at the Miami GRECC, Miami VA Healthcare System in Florida. is Associate Director (clinical) at the San Antonio GRECC, Audie L. Murphy Memorial VA Hospital in Texas. is Associate Director (education & evaluation) at the Little Rock GRECC, Central Arkansas Veterans Healthcare System. is a Research Health Scientist at the Birmingham/Atlanta GRECC, Atlanta VA Medical Center in Decatur, Georgia. is a Geriatrician at the Eastern Colorado GRECC, VA Eastern Colorado Health Care System in Denver. is Associate Director (clinical) at the Pittsburgh GRECC, VA Pittsburgh Healthcare System in Pennsylvania. is Associate Director (education & evaluation) at the Puget Sound GRECC, Puget Sound VA Medical Center in Seattle, Washington
| | - Patricia C Griffiths
- is a Research Health Scientist at the Center for Healthcare Organization and Implementation Research and the New England Geriatric Research Education and Clinical Center (GRECC), and is a Program Manager and is Site Director at the New England GRECC, Edith Nourse Rogers Memorial Veterans Hospital in Bedford, Massachusetts. is a Physician at Madison GRECC, William S. Middleton Memorial Veterans Hospital in Wisconsin. is Associate Director (research), J is Deputy Director, and is Associate Director (clinical) at Bronx/NY Harbor GRECC, James J. Peters Veterans Affairs Medical Center in New York. is a Geriatrician and is Associate Director (clinical) at the Birmingham/Atlanta GRECC in Alabama. is a Geriatrician at the Canandaigua VA Medical Center in New York. is Associate Director (clinical) at the Durham GRECC, Durham VA Medical Center in North Carolina. and are Geriatricians at the Miami GRECC, Miami VA Healthcare System in Florida. is Associate Director (clinical) at the San Antonio GRECC, Audie L. Murphy Memorial VA Hospital in Texas. is Associate Director (education & evaluation) at the Little Rock GRECC, Central Arkansas Veterans Healthcare System. is a Research Health Scientist at the Birmingham/Atlanta GRECC, Atlanta VA Medical Center in Decatur, Georgia. is a Geriatrician at the Eastern Colorado GRECC, VA Eastern Colorado Health Care System in Denver. is Associate Director (clinical) at the Pittsburgh GRECC, VA Pittsburgh Healthcare System in Pennsylvania. is Associate Director (education & evaluation) at the Puget Sound GRECC, Puget Sound VA Medical Center in Seattle, Washington
| | - Judith L Howe
- is a Research Health Scientist at the Center for Healthcare Organization and Implementation Research and the New England Geriatric Research Education and Clinical Center (GRECC), and is a Program Manager and is Site Director at the New England GRECC, Edith Nourse Rogers Memorial Veterans Hospital in Bedford, Massachusetts. is a Physician at Madison GRECC, William S. Middleton Memorial Veterans Hospital in Wisconsin. is Associate Director (research), J is Deputy Director, and is Associate Director (clinical) at Bronx/NY Harbor GRECC, James J. Peters Veterans Affairs Medical Center in New York. is a Geriatrician and is Associate Director (clinical) at the Birmingham/Atlanta GRECC in Alabama. is a Geriatrician at the Canandaigua VA Medical Center in New York. is Associate Director (clinical) at the Durham GRECC, Durham VA Medical Center in North Carolina. and are Geriatricians at the Miami GRECC, Miami VA Healthcare System in Florida. is Associate Director (clinical) at the San Antonio GRECC, Audie L. Murphy Memorial VA Hospital in Texas. is Associate Director (education & evaluation) at the Little Rock GRECC, Central Arkansas Veterans Healthcare System. is a Research Health Scientist at the Birmingham/Atlanta GRECC, Atlanta VA Medical Center in Decatur, Georgia. is a Geriatrician at the Eastern Colorado GRECC, VA Eastern Colorado Health Care System in Denver. is Associate Director (clinical) at the Pittsburgh GRECC, VA Pittsburgh Healthcare System in Pennsylvania. is Associate Director (education & evaluation) at the Puget Sound GRECC, Puget Sound VA Medical Center in Seattle, Washington
| | - Hillary D Lum
- is a Research Health Scientist at the Center for Healthcare Organization and Implementation Research and the New England Geriatric Research Education and Clinical Center (GRECC), and is a Program Manager and is Site Director at the New England GRECC, Edith Nourse Rogers Memorial Veterans Hospital in Bedford, Massachusetts. is a Physician at Madison GRECC, William S. Middleton Memorial Veterans Hospital in Wisconsin. is Associate Director (research), J is Deputy Director, and is Associate Director (clinical) at Bronx/NY Harbor GRECC, James J. Peters Veterans Affairs Medical Center in New York. is a Geriatrician and is Associate Director (clinical) at the Birmingham/Atlanta GRECC in Alabama. is a Geriatrician at the Canandaigua VA Medical Center in New York. is Associate Director (clinical) at the Durham GRECC, Durham VA Medical Center in North Carolina. and are Geriatricians at the Miami GRECC, Miami VA Healthcare System in Florida. is Associate Director (clinical) at the San Antonio GRECC, Audie L. Murphy Memorial VA Hospital in Texas. is Associate Director (education & evaluation) at the Little Rock GRECC, Central Arkansas Veterans Healthcare System. is a Research Health Scientist at the Birmingham/Atlanta GRECC, Atlanta VA Medical Center in Decatur, Georgia. is a Geriatrician at the Eastern Colorado GRECC, VA Eastern Colorado Health Care System in Denver. is Associate Director (clinical) at the Pittsburgh GRECC, VA Pittsburgh Healthcare System in Pennsylvania. is Associate Director (education & evaluation) at the Puget Sound GRECC, Puget Sound VA Medical Center in Seattle, Washington
| | - Alayne D Markland
- is a Research Health Scientist at the Center for Healthcare Organization and Implementation Research and the New England Geriatric Research Education and Clinical Center (GRECC), and is a Program Manager and is Site Director at the New England GRECC, Edith Nourse Rogers Memorial Veterans Hospital in Bedford, Massachusetts. is a Physician at Madison GRECC, William S. Middleton Memorial Veterans Hospital in Wisconsin. is Associate Director (research), J is Deputy Director, and is Associate Director (clinical) at Bronx/NY Harbor GRECC, James J. Peters Veterans Affairs Medical Center in New York. is a Geriatrician and is Associate Director (clinical) at the Birmingham/Atlanta GRECC in Alabama. is a Geriatrician at the Canandaigua VA Medical Center in New York. is Associate Director (clinical) at the Durham GRECC, Durham VA Medical Center in North Carolina. and are Geriatricians at the Miami GRECC, Miami VA Healthcare System in Florida. is Associate Director (clinical) at the San Antonio GRECC, Audie L. Murphy Memorial VA Hospital in Texas. is Associate Director (education & evaluation) at the Little Rock GRECC, Central Arkansas Veterans Healthcare System. is a Research Health Scientist at the Birmingham/Atlanta GRECC, Atlanta VA Medical Center in Decatur, Georgia. is a Geriatrician at the Eastern Colorado GRECC, VA Eastern Colorado Health Care System in Denver. is Associate Director (clinical) at the Pittsburgh GRECC, VA Pittsburgh Healthcare System in Pennsylvania. is Associate Director (education & evaluation) at the Puget Sound GRECC, Puget Sound VA Medical Center in Seattle, Washington
| | - Michelle I Rossi
- is a Research Health Scientist at the Center for Healthcare Organization and Implementation Research and the New England Geriatric Research Education and Clinical Center (GRECC), and is a Program Manager and is Site Director at the New England GRECC, Edith Nourse Rogers Memorial Veterans Hospital in Bedford, Massachusetts. is a Physician at Madison GRECC, William S. Middleton Memorial Veterans Hospital in Wisconsin. is Associate Director (research), J is Deputy Director, and is Associate Director (clinical) at Bronx/NY Harbor GRECC, James J. Peters Veterans Affairs Medical Center in New York. is a Geriatrician and is Associate Director (clinical) at the Birmingham/Atlanta GRECC in Alabama. is a Geriatrician at the Canandaigua VA Medical Center in New York. is Associate Director (clinical) at the Durham GRECC, Durham VA Medical Center in North Carolina. and are Geriatricians at the Miami GRECC, Miami VA Healthcare System in Florida. is Associate Director (clinical) at the San Antonio GRECC, Audie L. Murphy Memorial VA Hospital in Texas. is Associate Director (education & evaluation) at the Little Rock GRECC, Central Arkansas Veterans Healthcare System. is a Research Health Scientist at the Birmingham/Atlanta GRECC, Atlanta VA Medical Center in Decatur, Georgia. is a Geriatrician at the Eastern Colorado GRECC, VA Eastern Colorado Health Care System in Denver. is Associate Director (clinical) at the Pittsburgh GRECC, VA Pittsburgh Healthcare System in Pennsylvania. is Associate Director (education & evaluation) at the Puget Sound GRECC, Puget Sound VA Medical Center in Seattle, Washington
| | - Stephen M Thielke
- is a Research Health Scientist at the Center for Healthcare Organization and Implementation Research and the New England Geriatric Research Education and Clinical Center (GRECC), and is a Program Manager and is Site Director at the New England GRECC, Edith Nourse Rogers Memorial Veterans Hospital in Bedford, Massachusetts. is a Physician at Madison GRECC, William S. Middleton Memorial Veterans Hospital in Wisconsin. is Associate Director (research), J is Deputy Director, and is Associate Director (clinical) at Bronx/NY Harbor GRECC, James J. Peters Veterans Affairs Medical Center in New York. is a Geriatrician and is Associate Director (clinical) at the Birmingham/Atlanta GRECC in Alabama. is a Geriatrician at the Canandaigua VA Medical Center in New York. is Associate Director (clinical) at the Durham GRECC, Durham VA Medical Center in North Carolina. and are Geriatricians at the Miami GRECC, Miami VA Healthcare System in Florida. is Associate Director (clinical) at the San Antonio GRECC, Audie L. Murphy Memorial VA Hospital in Texas. is Associate Director (education & evaluation) at the Little Rock GRECC, Central Arkansas Veterans Healthcare System. is a Research Health Scientist at the Birmingham/Atlanta GRECC, Atlanta VA Medical Center in Decatur, Georgia. is a Geriatrician at the Eastern Colorado GRECC, VA Eastern Colorado Health Care System in Denver. is Associate Director (clinical) at the Pittsburgh GRECC, VA Pittsburgh Healthcare System in Pennsylvania. is Associate Director (education & evaluation) at the Puget Sound GRECC, Puget Sound VA Medical Center in Seattle, Washington
| | - Willy M Valencia-Rodrigo
- is a Research Health Scientist at the Center for Healthcare Organization and Implementation Research and the New England Geriatric Research Education and Clinical Center (GRECC), and is a Program Manager and is Site Director at the New England GRECC, Edith Nourse Rogers Memorial Veterans Hospital in Bedford, Massachusetts. is a Physician at Madison GRECC, William S. Middleton Memorial Veterans Hospital in Wisconsin. is Associate Director (research), J is Deputy Director, and is Associate Director (clinical) at Bronx/NY Harbor GRECC, James J. Peters Veterans Affairs Medical Center in New York. is a Geriatrician and is Associate Director (clinical) at the Birmingham/Atlanta GRECC in Alabama. is a Geriatrician at the Canandaigua VA Medical Center in New York. is Associate Director (clinical) at the Durham GRECC, Durham VA Medical Center in North Carolina. and are Geriatricians at the Miami GRECC, Miami VA Healthcare System in Florida. is Associate Director (clinical) at the San Antonio GRECC, Audie L. Murphy Memorial VA Hospital in Texas. is Associate Director (education & evaluation) at the Little Rock GRECC, Central Arkansas Veterans Healthcare System. is a Research Health Scientist at the Birmingham/Atlanta GRECC, Atlanta VA Medical Center in Decatur, Georgia. is a Geriatrician at the Eastern Colorado GRECC, VA Eastern Colorado Health Care System in Denver. is Associate Director (clinical) at the Pittsburgh GRECC, VA Pittsburgh Healthcare System in Pennsylvania. is Associate Director (education & evaluation) at the Puget Sound GRECC, Puget Sound VA Medical Center in Seattle, Washington
| | - Lauren R Moo
- is a Research Health Scientist at the Center for Healthcare Organization and Implementation Research and the New England Geriatric Research Education and Clinical Center (GRECC), and is a Program Manager and is Site Director at the New England GRECC, Edith Nourse Rogers Memorial Veterans Hospital in Bedford, Massachusetts. is a Physician at Madison GRECC, William S. Middleton Memorial Veterans Hospital in Wisconsin. is Associate Director (research), J is Deputy Director, and is Associate Director (clinical) at Bronx/NY Harbor GRECC, James J. Peters Veterans Affairs Medical Center in New York. is a Geriatrician and is Associate Director (clinical) at the Birmingham/Atlanta GRECC in Alabama. is a Geriatrician at the Canandaigua VA Medical Center in New York. is Associate Director (clinical) at the Durham GRECC, Durham VA Medical Center in North Carolina. and are Geriatricians at the Miami GRECC, Miami VA Healthcare System in Florida. is Associate Director (clinical) at the San Antonio GRECC, Audie L. Murphy Memorial VA Hospital in Texas. is Associate Director (education & evaluation) at the Little Rock GRECC, Central Arkansas Veterans Healthcare System. is a Research Health Scientist at the Birmingham/Atlanta GRECC, Atlanta VA Medical Center in Decatur, Georgia. is a Geriatrician at the Eastern Colorado GRECC, VA Eastern Colorado Health Care System in Denver. is Associate Director (clinical) at the Pittsburgh GRECC, VA Pittsburgh Healthcare System in Pennsylvania. is Associate Director (education & evaluation) at the Puget Sound GRECC, Puget Sound VA Medical Center in Seattle, Washington
| | - William W Hung
- is a Research Health Scientist at the Center for Healthcare Organization and Implementation Research and the New England Geriatric Research Education and Clinical Center (GRECC), and is a Program Manager and is Site Director at the New England GRECC, Edith Nourse Rogers Memorial Veterans Hospital in Bedford, Massachusetts. is a Physician at Madison GRECC, William S. Middleton Memorial Veterans Hospital in Wisconsin. is Associate Director (research), J is Deputy Director, and is Associate Director (clinical) at Bronx/NY Harbor GRECC, James J. Peters Veterans Affairs Medical Center in New York. is a Geriatrician and is Associate Director (clinical) at the Birmingham/Atlanta GRECC in Alabama. is a Geriatrician at the Canandaigua VA Medical Center in New York. is Associate Director (clinical) at the Durham GRECC, Durham VA Medical Center in North Carolina. and are Geriatricians at the Miami GRECC, Miami VA Healthcare System in Florida. is Associate Director (clinical) at the San Antonio GRECC, Audie L. Murphy Memorial VA Hospital in Texas. is Associate Director (education & evaluation) at the Little Rock GRECC, Central Arkansas Veterans Healthcare System. is a Research Health Scientist at the Birmingham/Atlanta GRECC, Atlanta VA Medical Center in Decatur, Georgia. is a Geriatrician at the Eastern Colorado GRECC, VA Eastern Colorado Health Care System in Denver. is Associate Director (clinical) at the Pittsburgh GRECC, VA Pittsburgh Healthcare System in Pennsylvania. is Associate Director (education & evaluation) at the Puget Sound GRECC, Puget Sound VA Medical Center in Seattle, Washington
| |
Collapse
|
10
|
Trudeau S, Gately M. Dementia and Occupational Therapy: A Practitioner Survey. Am J Occup Ther 2015. [DOI: 10.5014/ajot.2015.69s1-po7093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Abstract
Date Presented 4/18/2015
Occupational therapy practice for clients with advanced dementia is currently not well defined. Results from a practitioner survey include interventions (type, perceived effectiveness, and priorities) and perceived barriers to practice, which begin to describe the role of occupational therapy with a growing population.
Collapse
Affiliation(s)
- Scott Trudeau
- Veterans Affairs Medical Center, Bedford, Massachusetts
| | - Megan Gately
- Veterans Affairs Medical Center, Bedford, Massachusetts
| |
Collapse
|
11
|
Casey R, O'Hara MC, Cunningham A, Wall D, Geoghegan R, Hynes L, McGuire B, Gately M, Bell M, Dinneen SF. Young adult type 1 diabetes care in the West of Ireland: an audit of hospital practice. QJM 2014; 107:903-8. [PMID: 24925824 DOI: 10.1093/qjmed/hcu103] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND It is well recognised that management of young adults with type 1 diabetes (T1DM) poses difficult challenges for physicians and health care organisations as a whole. In Ireland and in particular the west of Ireland there has been little audit or research on young adults with T1DM and the services available to them. DESIGN In 2011 a retrospective review of this patient population in our territory referral centre was carried out. RESULTS The average glycaemic control in this population was poor at 81mmols/mol and diabetes related complications were present in 32%. Engagement by this population with services was poor with an average of 3 missed clinic appointments over a 24 month period. CONCLUSION These results have prompted a re think of how health care professionals can deliver a service that better suits the needs of this challenging patient group.
Collapse
Affiliation(s)
- R Casey
- From the Endocrinology and Diabetes Centre, Galway University Hospitals, Galway, Ireland, School of Medicine, NUI Galway, Galway, Ireland, School of Mathematics, Statistics and Applied Mathematics, NUI Galway, Galway, Ireland, Department of Paediatrics, Galway University Hospitals, Galway, Ireland and School of Psychology, NUI Galway, Galway, Ireland From the Endocrinology and Diabetes Centre, Galway University Hospitals, Galway, Ireland, School of Medicine, NUI Galway, Galway, Ireland, School of Mathematics, Statistics and Applied Mathematics, NUI Galway, Galway, Ireland, Department of Paediatrics, Galway University Hospitals, Galway, Ireland and School of Psychology, NUI Galway, Galway, Ireland
| | - M C O'Hara
- From the Endocrinology and Diabetes Centre, Galway University Hospitals, Galway, Ireland, School of Medicine, NUI Galway, Galway, Ireland, School of Mathematics, Statistics and Applied Mathematics, NUI Galway, Galway, Ireland, Department of Paediatrics, Galway University Hospitals, Galway, Ireland and School of Psychology, NUI Galway, Galway, Ireland From the Endocrinology and Diabetes Centre, Galway University Hospitals, Galway, Ireland, School of Medicine, NUI Galway, Galway, Ireland, School of Mathematics, Statistics and Applied Mathematics, NUI Galway, Galway, Ireland, Department of Paediatrics, Galway University Hospitals, Galway, Ireland and School of Psychology, NUI Galway, Galway, Ireland
| | - A Cunningham
- From the Endocrinology and Diabetes Centre, Galway University Hospitals, Galway, Ireland, School of Medicine, NUI Galway, Galway, Ireland, School of Mathematics, Statistics and Applied Mathematics, NUI Galway, Galway, Ireland, Department of Paediatrics, Galway University Hospitals, Galway, Ireland and School of Psychology, NUI Galway, Galway, Ireland From the Endocrinology and Diabetes Centre, Galway University Hospitals, Galway, Ireland, School of Medicine, NUI Galway, Galway, Ireland, School of Mathematics, Statistics and Applied Mathematics, NUI Galway, Galway, Ireland, Department of Paediatrics, Galway University Hospitals, Galway, Ireland and School of Psychology, NUI Galway, Galway, Ireland
| | - D Wall
- From the Endocrinology and Diabetes Centre, Galway University Hospitals, Galway, Ireland, School of Medicine, NUI Galway, Galway, Ireland, School of Mathematics, Statistics and Applied Mathematics, NUI Galway, Galway, Ireland, Department of Paediatrics, Galway University Hospitals, Galway, Ireland and School of Psychology, NUI Galway, Galway, Ireland
| | - R Geoghegan
- From the Endocrinology and Diabetes Centre, Galway University Hospitals, Galway, Ireland, School of Medicine, NUI Galway, Galway, Ireland, School of Mathematics, Statistics and Applied Mathematics, NUI Galway, Galway, Ireland, Department of Paediatrics, Galway University Hospitals, Galway, Ireland and School of Psychology, NUI Galway, Galway, Ireland
| | - L Hynes
- From the Endocrinology and Diabetes Centre, Galway University Hospitals, Galway, Ireland, School of Medicine, NUI Galway, Galway, Ireland, School of Mathematics, Statistics and Applied Mathematics, NUI Galway, Galway, Ireland, Department of Paediatrics, Galway University Hospitals, Galway, Ireland and School of Psychology, NUI Galway, Galway, Ireland
| | - B McGuire
- From the Endocrinology and Diabetes Centre, Galway University Hospitals, Galway, Ireland, School of Medicine, NUI Galway, Galway, Ireland, School of Mathematics, Statistics and Applied Mathematics, NUI Galway, Galway, Ireland, Department of Paediatrics, Galway University Hospitals, Galway, Ireland and School of Psychology, NUI Galway, Galway, Ireland
| | - M Gately
- From the Endocrinology and Diabetes Centre, Galway University Hospitals, Galway, Ireland, School of Medicine, NUI Galway, Galway, Ireland, School of Mathematics, Statistics and Applied Mathematics, NUI Galway, Galway, Ireland, Department of Paediatrics, Galway University Hospitals, Galway, Ireland and School of Psychology, NUI Galway, Galway, Ireland
| | - M Bell
- From the Endocrinology and Diabetes Centre, Galway University Hospitals, Galway, Ireland, School of Medicine, NUI Galway, Galway, Ireland, School of Mathematics, Statistics and Applied Mathematics, NUI Galway, Galway, Ireland, Department of Paediatrics, Galway University Hospitals, Galway, Ireland and School of Psychology, NUI Galway, Galway, Ireland From the Endocrinology and Diabetes Centre, Galway University Hospitals, Galway, Ireland, School of Medicine, NUI Galway, Galway, Ireland, School of Mathematics, Statistics and Applied Mathematics, NUI Galway, Galway, Ireland, Department of Paediatrics, Galway University Hospitals, Galway, Ireland and School of Psychology, NUI Galway, Galway, Ireland
| | - S F Dinneen
- From the Endocrinology and Diabetes Centre, Galway University Hospitals, Galway, Ireland, School of Medicine, NUI Galway, Galway, Ireland, School of Mathematics, Statistics and Applied Mathematics, NUI Galway, Galway, Ireland, Department of Paediatrics, Galway University Hospitals, Galway, Ireland and School of Psychology, NUI Galway, Galway, Ireland From the Endocrinology and Diabetes Centre, Galway University Hospitals, Galway, Ireland, School of Medicine, NUI Galway, Galway, Ireland, School of Mathematics, Statistics and Applied Mathematics, NUI Galway, Galway, Ireland, Department of Paediatrics, Galway University Hospitals, Galway, Ireland and School of Psychology, NUI Galway, Galway, Ireland
| |
Collapse
|
12
|
McDermott AM, Kidd P, Gately M, Casey R, Burke H, O'Donnell P, Kirrane F, Dinneen SF, O'Brien T. Restructuring of the Diabetes Day Centre: a pilot lean project in a tertiary referral centre in the West of Ireland. BMJ Qual Saf 2013; 22:681-8. [DOI: 10.1136/bmjqs-2012-001676] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
13
|
Dudley DJ, Hunter C, Mitchell MD, Varner MW, Gately M. Elevations of serum interleukin-12 concentrations in women with severe pre-eclampsia and HELLP syndrome. J Reprod Immunol 1996; 31:97-107. [PMID: 8887125 DOI: 10.1016/0165-0378(96)00976-x] [Citation(s) in RCA: 40] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
The objective is to test the hypothesis that serum IL-12 concentrations would be elevated in women with severe pre-eclampsia and HELLP syndrome. The Methods used were as follows: Serum was obtained from women admitted to our Labor and Delivery unit diagnosed with severe pre-eclampsia or HELLP syndrome and normal control patients. IL-12 concentrations in these samples were determined by the use of two different and specific enzyme-linked immunosorbent assays for the p40 subunit and the intact p75 dimer. It was found that serum IL-12 (p40 subunit) concentrations were elevated in women with both severe pre-eclampsia (p = 0.011) or HELLP syndrome (= 0.004). Similar findings were noted for these patients when matched with control patients for maternal age, gestational age, and parity. Eleven women had elevations of serum IL-12 p75 dimer, and 10 of these 11 patients had severe pre-eclampsia or HELLP syndrome. In conclusion, we found that women with severe pre-eclampsia and HELLP syndrome commonly have detectable concentrations of the IL-12 p40 monomer and were more likely than normal control women to have detectable serum IL-12 p75 dimer. While the exact role of IL-12 in hypertensive disease during pregnancy is unclear, our data support the hypothesis that the regulation of IL-12 production and metabolism is abnormal in women with pre-eclampsia and HELLP syndrome, perhaps contributing to the immunologic alterations characteristic of these disorders.
Collapse
Affiliation(s)
- D J Dudley
- University of Utah School of Medicine, Department of Obstetrics and Gynecology, Salt Lake City 84132, USA.
| | | | | | | | | |
Collapse
|
14
|
Lester MR, Hofer MF, Gately M, Trumble A, Leung DY. Down-regulating effects of IL-4 and IL-10 on the IFN-gamma response in atopic dermatitis. J Immunol 1995; 154:6174-81. [PMID: 7751657] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Atopic dermatitis (AD) is a chronic allergic disease associated with toxin (superantigen)-producing Staphylococcus aureus skin infections, impaired delayed hypersensitivity responses, and the expansion of IL-4-secreting Th2 cells, as well as diminished IFN-gamma synthesis. IL-12 is known to induce IFN-gamma synthesis and to augment Th1 responses. In this study, therefore, we examined the potential role of IL-12 in the immunopathogenesis of AD. We show that, after stimulation with staphylococcal toxic shock syndrome toxin-1 (TSST-1) or IL-12, PBMC from patients with AD are deficient in their ability to produce IFN-gamma. PBMC from AD patients, however, produced normal quantities of IL-12 and expressed normal levels of IL-12R. Induction of IFN-gamma by TSST-1 was decreased by neutralizing anti-IL-12 Ab in normal donors, but not in AD patients. The latter observation is consistent with a defective response to IL-12 in AD PBMC. Because AD is associated with increased production of IL-4 and IL-10, we examined the effect of IL-4 on IL-12- or TSST-1-induced IFN-gamma production in normal donors. IL-4 inhibited IL-12-induced IFN-gamma production. Furthermore, Ab neutralization of IL-4 caused increased production of IFN-gamma in AD PBMC. However, neutralization of IL-10 activity caused an even greater augmentation of IFN-gamma production. Our data suggest that despite normal levels of IL-12 production and IL-12R expression, PBMC from AD patients are unable to generate normal IL-12-induced IFN-gamma responses. This defective response may be due to the excess production of IL-4 and IL-10 in this common allergic condition.
Collapse
Affiliation(s)
- M R Lester
- Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206, USA
| | | | | | | | | |
Collapse
|
15
|
Lester MR, Hofer MF, Gately M, Trumble A, Leung DY. Down-regulating effects of IL-4 and IL-10 on the IFN-gamma response in atopic dermatitis. The Journal of Immunology 1995. [DOI: 10.4049/jimmunol.154.11.6174] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Abstract
Atopic dermatitis (AD) is a chronic allergic disease associated with toxin (superantigen)-producing Staphylococcus aureus skin infections, impaired delayed hypersensitivity responses, and the expansion of IL-4-secreting Th2 cells, as well as diminished IFN-gamma synthesis. IL-12 is known to induce IFN-gamma synthesis and to augment Th1 responses. In this study, therefore, we examined the potential role of IL-12 in the immunopathogenesis of AD. We show that, after stimulation with staphylococcal toxic shock syndrome toxin-1 (TSST-1) or IL-12, PBMC from patients with AD are deficient in their ability to produce IFN-gamma. PBMC from AD patients, however, produced normal quantities of IL-12 and expressed normal levels of IL-12R. Induction of IFN-gamma by TSST-1 was decreased by neutralizing anti-IL-12 Ab in normal donors, but not in AD patients. The latter observation is consistent with a defective response to IL-12 in AD PBMC. Because AD is associated with increased production of IL-4 and IL-10, we examined the effect of IL-4 on IL-12- or TSST-1-induced IFN-gamma production in normal donors. IL-4 inhibited IL-12-induced IFN-gamma production. Furthermore, Ab neutralization of IL-4 caused increased production of IFN-gamma in AD PBMC. However, neutralization of IL-10 activity caused an even greater augmentation of IFN-gamma production. Our data suggest that despite normal levels of IL-12 production and IL-12R expression, PBMC from AD patients are unable to generate normal IL-12-induced IFN-gamma responses. This defective response may be due to the excess production of IL-4 and IL-10 in this common allergic condition.
Collapse
Affiliation(s)
- M R Lester
- Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206, USA
| | - M F Hofer
- Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206, USA
| | - M Gately
- Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206, USA
| | - A Trumble
- Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206, USA
| | - D Y Leung
- Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206, USA
| |
Collapse
|
16
|
Shu U, Kiniwa M, Wu CY, Maliszewski C, Vezzio N, Hakimi J, Gately M, Delespesse G. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol 1995; 25:1125-8. [PMID: 7537673 DOI: 10.1002/eji.1830250442] [Citation(s) in RCA: 330] [Impact Index Per Article: 11.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
Previous studies on the production of interleukin-12 (IL-12) have shown that it is released, together with other proinflammatory cytokines, shortly after exposure of phagocytic cells to a variety of pathogens. We here report that IL-12 is also released during the recall response to soluble antigen (Ag) devoid of intrinsic adjuvant activity. We show that activated T cells induce the production of IL-12 by monocytes via a mechanism involving the interaction of T cell-associated CD40 ligand with CD40 on monocytes. The data suggest that Ag presentation on monocytes favors the persistence of type 1 responses.
Collapse
Affiliation(s)
- U Shu
- University of Montreal, Notre-Dame Hospital Research Center, Quebec, Canada
| | | | | | | | | | | | | | | |
Collapse
|
17
|
Leung DY, Gately M, Trumble A, Ferguson-Darnell B, Schlievert PM, Picker LJ. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med 1995; 181:747-53. [PMID: 7836926 PMCID: PMC2191866 DOI: 10.1084/jem.181.2.747] [Citation(s) in RCA: 217] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
T lymphocyte infiltration is a prominent feature of the skin inflammation associated with infections by toxin (superantigen)-secreting Staphylococcus aureus or Streptococcus bacteria. The cutaneous lymphocyte-associated antigen (CLA) has been hypothesized to be a homing receptor (HR) involved in selective migration of memory/effector T cells to the skin. Since the expression of this putative skin-selective HR is known to be under strict microenvironmental control, we sought to determine the effect of staphylococcal and streptococcal toxins on T cell expression of CLA. After in vitro stimulation of peripheral blood mononuclear cells with staphylococcal enterotoxin B, toxic shock syndrome toxin-1, and streptococcal pyrogenic exotoxins A and C, there was a significant increase in the numbers of CLA+ T cell blasts (p < 0.01), but not blasts bearing the mucosa-associated adhesion molecule alpha e beta 7-integrin, compared with T cells stimulated with phytohemaglutinin (PHA) or anti-CD3. Bacterial toxins were also found to specifically induce interleukin (IL) 12 production. More importantly, induction of toxin-induced CLA expression was blocked by anti-IL-12, and the addition of IL-12 to PHA-stimulated T cells induced CLA, but not alpha e beta 7-integrin, expression. These data suggest that bacterial toxins induce the expansion of skin-homing CLA+ T cells in an IL-12-dependent manner, and thus may contribute to the development of skin rashes in superantigen-mediated diseases.
Collapse
Affiliation(s)
- D Y Leung
- Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206
| | | | | | | | | | | |
Collapse
|
18
|
Zitvogel L, Tahara H, Cai Q, Storkus WJ, Muller G, Wolf SF, Gately M, Robbins PD, Lotze MT. Construction and characterization of retroviral vectors expressing biologically active human interleukin-12. Hum Gene Ther 1994; 5:1493-506. [PMID: 7711142 DOI: 10.1089/hum.1994.5.12-1493] [Citation(s) in RCA: 96] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
Abstract
Interleukin-12 (IL-12) is a heterodimeric cytokine originally defined by its ability to induce the maturation of cytolytic lymphocytes and by its capacity to effectively synergize with IL-2 in the induction of cytolytic activity. Recent studies in mice have demonstrated the ability of IL-12 to cause tumor regression and stimulate long-term antitumor immunity in treated animals. To examine the antitumor effect of direct gene transfer of IL-12 into tumors, we have developed retroviral vectors that coordinately express both subunits of IL-12. An MFG-based retroviral vector was used to generate a recombinant retrovirus in which a long terminal repeat (LTR)-driven polycistronic transcript encodes both subunits of human IL-12: hp35 and hp40 cDNAs are linked and coexpressed using the internal ribosome entry site (IRES) from the encephalomyocarditis virus (DFG-hIL-12). In addition, two IRES sequences were used to express both subunits of IL-12 and a neomycin resistance (neoR) selectable marker gene from the same polycistronic message (TFG-hIL-12). The amphotropic DFG-hIL-12 and TFG-hIL-12 viruses were used to infect both human and murine cell lines as well as primary tumor cultures. The production of human IL-12 by the nonselected, infected cells was measured in both a PHA blast proliferation bioassay and an ELISA and ranged from 15 to 40 ng/10(6) cells per 24 hr. Following G418 selection of TFG-hIL-12-infected cells, the level of expression of IL-12 was significantly higher (up to 120 ng/10(6) cells per 24 hr). The IL-12 protein secreted by the infected cells exhibited all of the biologic activities of recombinant hIL-12: proliferation of activated natural killer (NK) and T cells, stimulation of interferon-gamma (IFN-gamma) induction by NK and T cells, and enhancement of lymphokine-activated killer (LAK) activity. These retroviral vectors expressing human IL-12 should be useful in evaluating the biological properties of IL-12 as well as for use in clinical trials for gene therapy of patients with cancer.
Collapse
Affiliation(s)
- L Zitvogel
- Department of Surgery, University of Pittsburgh School of Medicine, PA 15261
| | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Ozmen L, Pericin M, Hakimi J, Chizzonite RA, Wysocka M, Trinchieri G, Gately M, Garotta G. Interleukin 12, interferon gamma, and tumor necrosis factor alpha are the key cytokines of the generalized Shwartzman reaction. J Exp Med 1994; 180:907-15. [PMID: 7914909 PMCID: PMC2191644 DOI: 10.1084/jem.180.3.907] [Citation(s) in RCA: 185] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Abstract
The Shwartzman reaction is elicited by two injections of lipopolysaccharide (LPS) in mice. The priming LPS injection is given in the footpad, whereas the lethal LPS challenge is given intravenously 24 h later. The injection of interferon gamma (IFN-gamma) or interleukin 12 (IL-12) instead of the LPS priming injection induced the lethal reaction in mice further challenged with LPS. Antibodies against IFN-gamma when given together with the priming agent, prevented the lethal reaction in mice primed with either LPS, IL-12, or IFN-gamma. Antibodies against IL-12, when given together with the priming agent, prevented the lethal reaction in mice primed with either LPS or IL-12 but not with IFN-gamma. These results strongly suggest that LPS induces the release of IL-12, that IL-12 induces the production of IFN-gamma, and that IFN-gamma is the cytokine that primes macrophages and other cell types. Upon LPS challenge, the lethal Shwartzman reaction is induced by a massive production of inflammatory cytokines that act on the target sites already sensitized by IFN-gamma. If mixtures of TNF and IL-1 or mixtures of TNF and IFN-gamma are used to challenge mice previously primed with IFN-gamma or IL-12, mortality is induced. In the same conditions, the individual cytokines or a mixture of IL-1 and IFN-gamma do not replace the LPS challenge. When the mice are primed with LPS, the combination of TNF, IL-1, and IFN-gamma induced only a partial mortality incidence suggesting that the involvement of other LPS-induced factors.
Collapse
Affiliation(s)
- L Ozmen
- Hoffmann La-Roche, Pharma Research New Technologies, Basel, Switzerland
| | | | | | | | | | | | | | | |
Collapse
|
20
|
Wu CY, Demeure CE, Gately M, Podlaski F, Yssel H, Kiniwa M, Delespesse G. In vitro maturation of human neonatal CD4 T lymphocytes. I. Induction of IL-4-producing cells after long-term culture in the presence of IL-4 plus either IL-2 or IL-12. The Journal of Immunology 1994. [DOI: 10.4049/jimmunol.152.3.1141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Abstract
Recent studies in the mouse have established that IL-4 and IL-12 direct the development of Ag-stimulated naive CD4 T cells into, respectively, type 2 and type 1 Th cells. We report that prolonged exposure of immunologically naive and unstimulated human neonatal CD4 T cells to IL-4 or to IL-4 plus either IL-2 or IL-12 markedly affects their cytokine production on primary stimulation with PMA and ionomycin. IL-4 induces long-term proliferation of neonatal T cells and after 3 wk of culture these are capable of producing high levels of Th1 (IL-2, IFN-gamma) but no Th2 (IL-4, IL-5) cytokines; IL-4-primed cells are homogenously CD45RO-/RA+ and CD31+. After culture in the presence of IL-4 + IL-2 or IL-4 + IL-12, neonatal T cells are enriched in CD45RO+ and CD31- cells and they can produce Th2 as well as Th1 cytokines. In response to primary stimulation with PMA and ionomycin, cells primed with IL-4 + IL-2 produce IL-4, IL-5, and IL-10 and the same levels of IL-2 and IFN-gamma as IL-4-primed cells. Cells primed with IL-4 + IL-12 produce very high levels of both IL-4 and IFN-gamma but no IL-5. Endogenous IFN-gamma that is detected in primary cultures containing IL-4 + IL-12 does not inhibit, but rather enhances, the ability of the cells to produce IL-4. Further analysis of IL-4 + IL-12-primed cells reveals that IL-4 is mainly produced by CD31- cells and that these cells can trigger B cells to synthesize Ig including IgE. Finally, positively selected CD31+ cells remain CD31+ and are poor IL-4 producers after 3 wk of culture with IL-4 + IL-12, suggesting that these two cytokines promote the selective expansion of the small number of CD31- cells that are present in freshly isolated neonatal CD4 T cells.
Collapse
Affiliation(s)
- C Y Wu
- University of Montreal, Notre-Dame Hospital Research Center, Canada
| | - C E Demeure
- University of Montreal, Notre-Dame Hospital Research Center, Canada
| | - M Gately
- University of Montreal, Notre-Dame Hospital Research Center, Canada
| | - F Podlaski
- University of Montreal, Notre-Dame Hospital Research Center, Canada
| | - H Yssel
- University of Montreal, Notre-Dame Hospital Research Center, Canada
| | - M Kiniwa
- University of Montreal, Notre-Dame Hospital Research Center, Canada
| | - G Delespesse
- University of Montreal, Notre-Dame Hospital Research Center, Canada
| |
Collapse
|
21
|
Wu CY, Demeure CE, Gately M, Podlaski F, Yssel H, Kiniwa M, Delespesse G. In vitro maturation of human neonatal CD4 T lymphocytes. I. Induction of IL-4-producing cells after long-term culture in the presence of IL-4 plus either IL-2 or IL-12. J Immunol 1994; 152:1141-53. [PMID: 7905497] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
Abstract
Recent studies in the mouse have established that IL-4 and IL-12 direct the development of Ag-stimulated naive CD4 T cells into, respectively, type 2 and type 1 Th cells. We report that prolonged exposure of immunologically naive and unstimulated human neonatal CD4 T cells to IL-4 or to IL-4 plus either IL-2 or IL-12 markedly affects their cytokine production on primary stimulation with PMA and ionomycin. IL-4 induces long-term proliferation of neonatal T cells and after 3 wk of culture these are capable of producing high levels of Th1 (IL-2, IFN-gamma) but no Th2 (IL-4, IL-5) cytokines; IL-4-primed cells are homogenously CD45RO-/RA+ and CD31+. After culture in the presence of IL-4 + IL-2 or IL-4 + IL-12, neonatal T cells are enriched in CD45RO+ and CD31- cells and they can produce Th2 as well as Th1 cytokines. In response to primary stimulation with PMA and ionomycin, cells primed with IL-4 + IL-2 produce IL-4, IL-5, and IL-10 and the same levels of IL-2 and IFN-gamma as IL-4-primed cells. Cells primed with IL-4 + IL-12 produce very high levels of both IL-4 and IFN-gamma but no IL-5. Endogenous IFN-gamma that is detected in primary cultures containing IL-4 + IL-12 does not inhibit, but rather enhances, the ability of the cells to produce IL-4. Further analysis of IL-4 + IL-12-primed cells reveals that IL-4 is mainly produced by CD31- cells and that these cells can trigger B cells to synthesize Ig including IgE. Finally, positively selected CD31+ cells remain CD31+ and are poor IL-4 producers after 3 wk of culture with IL-4 + IL-12, suggesting that these two cytokines promote the selective expansion of the small number of CD31- cells that are present in freshly isolated neonatal CD4 T cells.
Collapse
Affiliation(s)
- C Y Wu
- University of Montreal, Notre-Dame Hospital Research Center, Canada
| | | | | | | | | | | | | |
Collapse
|
22
|
Wu CY, Demeure C, Kiniwa M, Gately M, Delespesse G. IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells. J Immunol 1993; 151:1938-49. [PMID: 8102154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
A major difference between "naive" and "memory" or "effector" Th cells is the spectrum of cytokines that they are capable of producing. After stimulation naive cells produce only IL-2, whereas memory cells produce several cytokines including IFN-gamma and IL-4. Using umbilical cord blood-derived CD4 T cells as a source of naive T cells, we first report that these cells are capable of producing large amounts of IFN-gamma when cultured with low concentrations of IL-12. The response is time- and dose-dependent, and it is observed at the protein and mRNA levels. IL-12 also induces neonatal CD4 T cells to produce lymphotoxin but not IL-2, TNF-alpha, or IL-4. The production of IFN-gamma by IL-12-stimulated neonatal T cells is associated with a small but significant T cell activation evidenced by DNA synthesis and by the expression of the activation markers CD25, CD71, and HLA-DR; moreover, it is inhibited by hydrocortisone, cyclosporin A, and transforming growth factor-beta. The response to IL-12 is enhanced and is much more rapid when CD4 T cells are cultured in the presence of accessory cells or of exogenous IL-1, IL-2, or TNF-alpha. Using a three-step culture system, we next show that IL-12 induces the maturation of resting naive CD4 T cells into cells producing both IL-2 and IFN-gamma but not IL-4 upon stimulation with PMA and ionomycin. Endogenously produced IFN-gamma plays a role in this IL-12-induced T cell maturation, as shown by the inhibitory effect of neutralizing IFN-gamma antibodies. Finally, we show that IL-12 supports the production of IFN-gamma during primary stimulation of neonatal T cells via the CD3/TCR complex by means of either immobilized anti-CD3 mAb or superantigen-coated (Staphylococcus enterotoxin B) fixed L cell transfectants expressing HLA-DR. It is suggested that IL-12 is involved in the selection of Th1 type immune responses.
Collapse
Affiliation(s)
- C Y Wu
- Notre-Dame Hospital Research Center, University of Montreal, Canada
| | | | | | | | | |
Collapse
|
23
|
Wu CY, Demeure C, Kiniwa M, Gately M, Delespesse G. IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells. The Journal of Immunology 1993. [DOI: 10.4049/jimmunol.151.4.1938] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Abstract
A major difference between "naive" and "memory" or "effector" Th cells is the spectrum of cytokines that they are capable of producing. After stimulation naive cells produce only IL-2, whereas memory cells produce several cytokines including IFN-gamma and IL-4. Using umbilical cord blood-derived CD4 T cells as a source of naive T cells, we first report that these cells are capable of producing large amounts of IFN-gamma when cultured with low concentrations of IL-12. The response is time- and dose-dependent, and it is observed at the protein and mRNA levels. IL-12 also induces neonatal CD4 T cells to produce lymphotoxin but not IL-2, TNF-alpha, or IL-4. The production of IFN-gamma by IL-12-stimulated neonatal T cells is associated with a small but significant T cell activation evidenced by DNA synthesis and by the expression of the activation markers CD25, CD71, and HLA-DR; moreover, it is inhibited by hydrocortisone, cyclosporin A, and transforming growth factor-beta. The response to IL-12 is enhanced and is much more rapid when CD4 T cells are cultured in the presence of accessory cells or of exogenous IL-1, IL-2, or TNF-alpha. Using a three-step culture system, we next show that IL-12 induces the maturation of resting naive CD4 T cells into cells producing both IL-2 and IFN-gamma but not IL-4 upon stimulation with PMA and ionomycin. Endogenously produced IFN-gamma plays a role in this IL-12-induced T cell maturation, as shown by the inhibitory effect of neutralizing IFN-gamma antibodies. Finally, we show that IL-12 supports the production of IFN-gamma during primary stimulation of neonatal T cells via the CD3/TCR complex by means of either immobilized anti-CD3 mAb or superantigen-coated (Staphylococcus enterotoxin B) fixed L cell transfectants expressing HLA-DR. It is suggested that IL-12 is involved in the selection of Th1 type immune responses.
Collapse
Affiliation(s)
- C Y Wu
- Notre-Dame Hospital Research Center, University of Montreal, Canada
| | - C Demeure
- Notre-Dame Hospital Research Center, University of Montreal, Canada
| | - M Kiniwa
- Notre-Dame Hospital Research Center, University of Montreal, Canada
| | - M Gately
- Notre-Dame Hospital Research Center, University of Montreal, Canada
| | - G Delespesse
- Notre-Dame Hospital Research Center, University of Montreal, Canada
| |
Collapse
|
24
|
Kiniwa M, Gately M, Gubler U, Chizzonite R, Fargeas C, Delespesse G. Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes. J Clin Invest 1992; 90:262-6. [PMID: 1353081 PMCID: PMC443090 DOI: 10.1172/jci115846] [Citation(s) in RCA: 165] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
Interleukin-12 is a recently discovered lymphokine displaying an array of in vitro activities suggesting a major role in protective immunity against infectious agents like viruses. This study provides evidence that IL-12 may also be implicated in the selection of the immunoglobulin isotypes. We show that picomolar concentrations of rIL-12 markedly inhibit the synthesis of IgE by IL-4-stimulated PBMC. The suppression of IgE is observed at the protein and at the mRNA levels, it is isotype specific, and it is abolished by neutralizing anti-IL-12 mAbs. IL-12 may suppress IgE synthesis by: (a) inducing the production of IFN-gamma, a known inhibitor of IgE synthesis and (b) by a novel mechanism which is IFN-gamma independent. The best evidence for this is from studies on IgE synthesis by IL-4-plus hydrocortisone-stimulated umbilical cord blood lymphocytes, which do not produce detectable amounts of IFN-gamma. In such cultures, rIL-12 inhibits IgE synthesis even in the presence of a large excess of neutralizing anti-IFN-gamma mAb.
Collapse
Affiliation(s)
- M Kiniwa
- University of Montreal, Notre-Dame Hospital Research Center, Quebec, Canada
| | | | | | | | | | | |
Collapse
|
25
|
Naume B, Gately M, Espevik T. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells. The Journal of Immunology 1992. [DOI: 10.4049/jimmunol.148.8.2429] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Abstract
IL-12, or cytotoxic lymphocyte maturation factor, is a recently cloned cytokine shown to influence lymphokine-activated killer cells activity in heterogeneous lymphocyte populations, proliferative activity as a costimulus in PBMC/PBL populations and IFN-gamma production in PBL. We have investigated the effects of IL-12 on immunomagnetically highly purified CD56+ lymphocytes, and compared the effects with those of IL-7 and IL-2. Our results show that IL-12 directly generated high lymphokine-activated killer cell activity in CD56+ NK cells, without the need for accessory cells. The IL-12-induced lymphokine-activated killer cell activity reached 50% of what was obtained with IL-2. In contrast, only low proliferative activity was induced by IL-12, as 10% of the IL-2-induced- and approximately 50% of the IL-7-induced proliferative activity was detected with IL-12. The CD56+ cells expressed high levels of IL-2R alpha and 75-kDa TNFR in response to IL-12, comparable to what was registered with IL-2 and IL-7. Furthermore, an extensive up-regulation of the CD56 Ag, to the level obtained with IL-2, was detected in the CD56+ NK cells in the presence of IL-12. Stimulation with IL-7 resulted in a more limited CD56 up-regulation in the CD56+ NK cells. Low concentrations of TNF-alpha were produced in response to both IL-12 and IL-7, with little or no TNF-beta production. Time course of the IL-2-induced TNF production revealed an initial TNF-alpha production, whereas significant levels of TNF-beta were detected after 72 h. The effects of both IL-12 and IL-7 on the CD56+ NK cells were inhibited by an anti-TNF-alpha mAb. Thus, IL-12 can directly influence NK cell activities in purified CD56+ cells, and endogenously produced TNF-alpha is involved in mediating the effects of both IL-12 and IL-7.
Collapse
Affiliation(s)
- B Naume
- Institute of Cancer Research, University of Trondheim, Norway
| | - M Gately
- Institute of Cancer Research, University of Trondheim, Norway
| | - T Espevik
- Institute of Cancer Research, University of Trondheim, Norway
| |
Collapse
|
26
|
Naume B, Gately M, Espevik T. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells. J Immunol 1992; 148:2429-36. [PMID: 1373169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/25/2023]
Abstract
IL-12, or cytotoxic lymphocyte maturation factor, is a recently cloned cytokine shown to influence lymphokine-activated killer cells activity in heterogeneous lymphocyte populations, proliferative activity as a costimulus in PBMC/PBL populations and IFN-gamma production in PBL. We have investigated the effects of IL-12 on immunomagnetically highly purified CD56+ lymphocytes, and compared the effects with those of IL-7 and IL-2. Our results show that IL-12 directly generated high lymphokine-activated killer cell activity in CD56+ NK cells, without the need for accessory cells. The IL-12-induced lymphokine-activated killer cell activity reached 50% of what was obtained with IL-2. In contrast, only low proliferative activity was induced by IL-12, as 10% of the IL-2-induced- and approximately 50% of the IL-7-induced proliferative activity was detected with IL-12. The CD56+ cells expressed high levels of IL-2R alpha and 75-kDa TNFR in response to IL-12, comparable to what was registered with IL-2 and IL-7. Furthermore, an extensive up-regulation of the CD56 Ag, to the level obtained with IL-2, was detected in the CD56+ NK cells in the presence of IL-12. Stimulation with IL-7 resulted in a more limited CD56 up-regulation in the CD56+ NK cells. Low concentrations of TNF-alpha were produced in response to both IL-12 and IL-7, with little or no TNF-beta production. Time course of the IL-2-induced TNF production revealed an initial TNF-alpha production, whereas significant levels of TNF-beta were detected after 72 h. The effects of both IL-12 and IL-7 on the CD56+ NK cells were inhibited by an anti-TNF-alpha mAb. Thus, IL-12 can directly influence NK cell activities in purified CD56+ cells, and endogenously produced TNF-alpha is involved in mediating the effects of both IL-12 and IL-7.
Collapse
MESH Headings
- Antibodies, Monoclonal/immunology
- Antigens, CD/analysis
- Antigens, Differentiation, T-Lymphocyte/analysis
- CD56 Antigen
- Cell Separation/methods
- Humans
- In Vitro Techniques
- Interleukin-12
- Interleukin-2/pharmacology
- Interleukin-7/pharmacology
- Interleukins/pharmacology
- Killer Cells, Lymphokine-Activated/drug effects
- Killer Cells, Lymphokine-Activated/immunology
- Killer Cells, Natural/drug effects
- Killer Cells, Natural/physiology
- Lymphocyte Activation/drug effects
- Lymphotoxin-alpha/biosynthesis
- Lymphotoxin-alpha/immunology
- Receptors, Cell Surface/analysis
- Receptors, Interleukin-2/analysis
- Receptors, Tumor Necrosis Factor
- Tumor Necrosis Factor-alpha/biosynthesis
- Tumor Necrosis Factor-alpha/immunology
Collapse
Affiliation(s)
- B Naume
- Institute of Cancer Research, University of Trondheim, Norway
| | | | | |
Collapse
|
27
|
Lorberboum-Galski H, Garsia RJ, Gately M, Brown PS, Clark RE, Waldmann TA, Chaudhary VK, FitzGerald DJ, Pastan I. IL2-PE664Glu, a new chimeric protein cytotoxic to human-activated T lymphocytes. J Biol Chem 1990; 265:16311-7. [PMID: 1975810] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
To produce a molecule that will kill activated T cells as well as lymphomas and leukemias expressing interleukin 2 (IL2) receptors, we have created a recombinant chimeric protein in which IL2 is attached in peptide linkage to a truncated mutant form of Pseudomonas exotoxin (PE) (Lorberboum-Galski, H., FitzGerald, D.J.P., Chandhary, V.K., Adhya, S., and Pastan, I. (1988) Proc. Natl. Acad. Sci. U.S.A. 85, 1922-1926). Although this molecule was very active on rodent cells, it had lower activity on some human cell types. A new chimeric protein termed IL2-PE664Glu has been constructed that is extremely toxic to both phytohemagglutinin blasts and mixed leukocyte reaction blasts prepared from monkey and human lymphocytes. The chimeric gene encoding this protein was constructed by fusing a cDNA clone for human interleukin 2 to the 5' end of a mutated cDNA encoding a full-length PE molecule. Four amino acids in domain I of PE were changed thus decreasing its nonspecific toxicity. IL2-PE664Glu is a much more active cytotoxic molecule for primate and human-activated T cells than IL2-PE40 which is a chimeric protein that was found to be an effective immunosuppressive agent in rodent models. Our results indicate that IL2-PE664Glu should be evaluated as an immunosuppressive agent for the treatment of human immune disorders in which activated T cells expressing the IL2 receptor are prominent.
Collapse
Affiliation(s)
- H Lorberboum-Galski
- Division of Cancer Biology and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892
| | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Batra JK, FitzGerald D, Gately M, Chaudhary VK, Pastan I. Anti-Tac(Fv)-PE40, a single chain antibody Pseudomonas fusion protein directed at interleukin 2 receptor bearing cells. J Biol Chem 1990; 265:15198-202. [PMID: 2118522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
Anti-Tac(Fv)-PE40 is a chimeric single chain immunotoxin in which anti-Tac variable heavy and light chains held together by a peptide linker are attached to PE40, a truncated form of Pseudomonas exotoxin. This molecule was shown to be extremely cytotoxic for interleukin 2 (IL2) receptor bearing cells in tissue culture (Chaudhary, V. K., Queen, C., Junghans, R. P., Waldmann, T. A., FitzGerald, D. J., and Pastan, I. (1989) Nature 339, 394-397). Here we describe various forms of anti-Tac(Fv)-PE40 protein in which the order of the variable domains of anti-Tac has been switched and also three different types of peptide linkers have been used. All these proteins were purified to near homogeneity and were found to have similar cytotoxic activities against various human cells expressing the p55 subunit of the IL2 receptor. Anti-Tac(Fv)-PE40 was also found to have a very potent suppressive activity against phytohemagglutinin-activated human lymphoblasts and in a human mixed lymphocyte reaction. Anti-Tac(Fv)-PE40 appeared in the blood rapidly in mice after intraperitoneal administration and could be detected in the blood for up to 8 h. Anti-Tac(Fv)-PE40 warrants evaluation as an anti-tumor and immunosuppressive agent in humans.
Collapse
Affiliation(s)
- J K Batra
- Division of Cancer Biology and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892
| | | | | | | | | |
Collapse
|
29
|
Sorg C, Geczy C, Geczy A, Hämmerling G, Gately M. Evidence that Ia-Antigens Are not Secreted by Antigen or Mitogen Stimulated Mouse or Guinea Pig Lymphocytes. ACTA ACUST UNITED AC 1978. [DOI: 10.1016/s0340-904x(78)80058-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|